HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.

AuthorsP Glogner, S Massarrat, H R Henrichs
JournalActa hepato-splenologica (Acta Hepatosplenol) 1971 Sep-Oct Vol. 18 Issue 5 Pg. 394-7 ISSN: 0001-5822 [Print] Germany
PMID5112056 (Publication Type: Journal Article)
Chemical References
  • Barbiturates
  • Sulfobromophthalein
  • Aspartate Aminotransferases
  • Alanine Transaminase
Topics
  • Alanine Transaminase (blood)
  • Aspartate Aminotransferases (blood)
  • Barbiturates (adverse effects, therapeutic use)
  • Biopsy
  • Enzyme Induction
  • Fatty Liver (drug therapy)
  • Hepatitis (drug therapy)
  • Liver Cirrhosis (drug therapy)
  • Liver Diseases (drug therapy)
  • Sulfobromophthalein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: